Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Meehan

Showing results (41-50 of 262) with videos related to

Pageof 27
Sort By:
Surgery|April 1, 1997
Pig to monkey bone marrow and kidney xenotransplantationT Sablinski, P R Gianello, M Bailin, et al.
Immunology and Cell Biology|May 6, 2022
The balance of interleukin-12 and interleukin-23 determines the bias of MAIT1 versus MAIT17 responses during bacterial infectionHuimeng Wang, Adam G Nelson, Bingjie Wang, et al.
Science Immunology|December 6, 2024
MAIT cell plasticity enables functional adaptation that drives antibacterial immune protectionHuimeng Wang, Michael N T Souter, Marcela de Lima Moreira, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2018
Mucosal-Associated Invariant T Cells Augment Immunopathology and Gastritis in Chronic <i>Helicobacter pylori</i> InfectionCriselle D'Souza, Troi Pediongco, Huimeng Wang, et al.
Frontiers in Immunology|September 18, 2023
Synthetic 5-amino-6-D-ribitylaminouracil paired with inflammatory stimuli facilitates MAIT cell expansion <i>in vivo</i>Adam G Nelson, Huimeng Wang, Phoebe M Dewar, et al.
The Journal of Biological Chemistry|May 5, 2024
MAIT cell-MR1 reactivity is highly conserved across multiple divergent speciesMatthew D Edmans, Timothy K Connelley, Sophie Morgan, et al.
Nature Communications|July 17, 2021
Francisella tularensis induces Th1 like MAIT cells conferring protection against systemic and local infectionZhe Zhao, Huimeng Wang, Mai Shi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 29, 2023
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 TrialConnie N Hess, Judith Hsia, Ian A Carroll, et al.
Nature Immunology|February 7, 2017
Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cellsAndrew N Keller, Sidonia B G Eckle, Weijun Xu, et al.
Oncotarget|November 20, 2020
Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomasGeraldine O'Sullivan Coyne, Shivaani Kummar, Robert S Meehan, et al.
Pageof 27

Showing results (41-50 of 262) with videos related to

Sort By:
Pageof 27
Surgery|April 1, 1997
Pig to monkey bone marrow and kidney xenotransplantationT Sablinski, P R Gianello, M Bailin, et al.
Immunology and Cell Biology|May 6, 2022
The balance of interleukin-12 and interleukin-23 determines the bias of MAIT1 versus MAIT17 responses during bacterial infectionHuimeng Wang, Adam G Nelson, Bingjie Wang, et al.
Science Immunology|December 6, 2024
MAIT cell plasticity enables functional adaptation that drives antibacterial immune protectionHuimeng Wang, Michael N T Souter, Marcela de Lima Moreira, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2018
Mucosal-Associated Invariant T Cells Augment Immunopathology and Gastritis in Chronic <i>Helicobacter pylori</i> InfectionCriselle D'Souza, Troi Pediongco, Huimeng Wang, et al.
Frontiers in Immunology|September 18, 2023
Synthetic 5-amino-6-D-ribitylaminouracil paired with inflammatory stimuli facilitates MAIT cell expansion <i>in vivo</i>Adam G Nelson, Huimeng Wang, Phoebe M Dewar, et al.
The Journal of Biological Chemistry|May 5, 2024
MAIT cell-MR1 reactivity is highly conserved across multiple divergent speciesMatthew D Edmans, Timothy K Connelley, Sophie Morgan, et al.
Nature Communications|July 17, 2021
Francisella tularensis induces Th1 like MAIT cells conferring protection against systemic and local infectionZhe Zhao, Huimeng Wang, Mai Shi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 29, 2023
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 TrialConnie N Hess, Judith Hsia, Ian A Carroll, et al.
Nature Immunology|February 7, 2017
Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cellsAndrew N Keller, Sidonia B G Eckle, Weijun Xu, et al.
Oncotarget|November 20, 2020
Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomasGeraldine O'Sullivan Coyne, Shivaani Kummar, Robert S Meehan, et al.
Pageof 27